527 related articles for article (PubMed ID: 9712743)
1. Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.
Igietseme JU; Uriri IM; Kumar SN; Ananaba GA; Ojior OO; Momodu IA; Candal DH; Black CM
Infect Immun; 1998 Sep; 66(9):4030-5. PubMed ID: 9712743
[TBL] [Abstract][Full Text] [Related]
2. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
[TBL] [Abstract][Full Text] [Related]
3. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response.
Johansson M; Schön K; Ward M; Lycke N
Infect Immun; 1997 Mar; 65(3):1032-44. PubMed ID: 9038313
[TBL] [Abstract][Full Text] [Related]
4. Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice.
Li Z; Wang S; Wu Y; Zhong G; Chen D
Sci China C Life Sci; 2008 Nov; 51(11):973-80. PubMed ID: 18989639
[TBL] [Abstract][Full Text] [Related]
5. Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice.
Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
J Microbiol Immunol Infect; 2005 Dec; 38(6):383-93. PubMed ID: 16341338
[TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection.
Su H; Parnell M; Caldwell HD
Vaccine; 1995 Aug; 13(11):1023-32. PubMed ID: 8525685
[TBL] [Abstract][Full Text] [Related]
7. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
Pal S; Theodor I; Peterson EM; de la Maza LM
Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798
[TBL] [Abstract][Full Text] [Related]
8. Immunological memory in B-cell-deficient mice conveys long-lasting protection against genital tract infection with Chlamydia trachomatis by rapid recruitment of T cells.
Johansson M; Lycke N
Immunology; 2001 Feb; 102(2):199-208. PubMed ID: 11260325
[TBL] [Abstract][Full Text] [Related]
9. The
Verma R; Sahu R; Dixit S; Duncan SA; Giambartolomei GH; Singh SR; Dennis VA
Front Immunol; 2018; 9():2369. PubMed ID: 30374357
[TBL] [Abstract][Full Text] [Related]
10.
Shillova N; Howe SE; Hyseni B; Ridgell D; Fisher DJ; Konjufca V
Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33139380
[No Abstract] [Full Text] [Related]
11. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes.
Igietseme JU; Murdin A
Infect Immun; 2000 Dec; 68(12):6798-806. PubMed ID: 11083798
[TBL] [Abstract][Full Text] [Related]
12. Fc receptor regulation of protective immunity against Chlamydia trachomatis.
Moore T; Ananaba GA; Bolier J; Bowers S; Belay T; Eko FO; Igietseme JU
Immunology; 2002 Feb; 105(2):213-21. PubMed ID: 11872097
[TBL] [Abstract][Full Text] [Related]
13. B-cell-deficient mice develop complete immune protection against genital tract infection with Chlamydia trachomatis.
Johansson M; Ward M; Lycke N
Immunology; 1997 Dec; 92(4):422-8. PubMed ID: 9497482
[TBL] [Abstract][Full Text] [Related]
14. Induction of protective immunity against a Chlamydia trachomatis genital infection in three genetically distinct strains of mice.
Pal S; Peterson EM; de la Maza LM
Immunology; 2003 Nov; 110(3):368-75. PubMed ID: 14632665
[TBL] [Abstract][Full Text] [Related]
15. Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains.
Su H; Messer R; Whitmire W; Hughes S; Caldwell HD
Infect Immun; 2000 Jan; 68(1):192-6. PubMed ID: 10603387
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection.
Berry LJ; Hickey DK; Skelding KA; Bao S; Rendina AM; Hansbro PM; Gockel CM; Beagley KW
Infect Immun; 2004 Feb; 72(2):1019-28. PubMed ID: 14742549
[TBL] [Abstract][Full Text] [Related]
17. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge.
Pal S; Luke CJ; Barbour AG; Peterson EM; de la Maza LM
Vaccine; 2003 Mar; 21(13-14):1455-65. PubMed ID: 12615442
[TBL] [Abstract][Full Text] [Related]
18. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection.
Morrison RP; Feilzer K; Tumas DB
Infect Immun; 1995 Dec; 63(12):4661-8. PubMed ID: 7591120
[TBL] [Abstract][Full Text] [Related]
19. Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice.
Su H; Feilzer K; Caldwell HD; Morrison RP
Infect Immun; 1997 Jun; 65(6):1993-9. PubMed ID: 9169723
[TBL] [Abstract][Full Text] [Related]
20. Route of Vaccine Administration Influences the Impact of Fms-Like Tyrosine Kinase 3 Ligand (Flt3L) on Chlamydial-Specific Protective Immune Responses.
Pais R; Omosun Y; Igietseme JU; Fujihashi K; Eko FO
Front Immunol; 2019; 10():1577. PubMed ID: 31333682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
